MedPath

Choline C-11

Generic Name
Choline C-11
Drug Type
Small Molecule
Chemical Formula
C5H14NO
CAS Number
94793-58-5
Unique Ingredient Identifier
M4AS4XGD4Q

Overview

Choline C 11 Injection is a radioactive diagnostic agent for positron emission tomography (PET) imaging of pat ients with suspected prostate cancer recurrence and non-informative bone scintigraphy, computerized tomography (CT) or magnetic resonance imaging.

Background

Choline C 11 Injection is a radioactive diagnostic agent for positron emission tomography (PET) imaging of pat ients with suspected prostate cancer recurrence and non-informative bone scintigraphy, computerized tomography (CT) or magnetic resonance imaging.

Indication

Choline C 11 Injection is indicated for positron emission tomography (PET) imaging of patients with suspected prostate cancer recurrence and non-informative bone scintigraphy, computerized tomography (CT) or magnetic resonance imaging (MRI). In these patients, 11 C-choline PET imaging may help identify potential sites of prostate cancer recurrence for subsequent histologic confirmation. Suspected prostate recurrence is based upon elevated blood prostate specific antigen (PSA) levels following initial therapy. In clinical studies, imag es w ere produced with PET/CT coregistration.

Associated Conditions

  • Prostate Cancer

Clinical Trials

No clinical trials found for this drug

FDA Approved Products

Choline C 11
Manufacturer:Mayo Clinic
Route:INTRAVENOUS
Strength:33.1 mCi in 1 mL
Approved: 2024/01/10
NDC:52670-556
Choline C 11
Manufacturer:Decatur Memorial Hospital
Route:INTRAVENOUS
Strength:4 mCi in 1 mL
Approved: 2019/11/06
NDC:73410-004
MIC B12
Manufacturer:Perdido Key Health and Wellness Inc
Route:INTRAMUSCULAR
Strength:1 mg in 1 mL
Approved: 2015/11/23
NDC:70104-806
Choline C 11
Manufacturer:The University of Texas MD Anderson Cancer Center
Route:INTRAVENOUS
Strength:100 mCi in 1 mL
Approved: 2017/12/19
NDC:60215-111

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath